The clinical significance of mannose-binding lectin (MBL) deficiency

The clinical significance of mannose-binding lectin (MBL) deficiency

Authors	F.N.J. Frakking
Supervisors	T.W. Kuijpers
Cosupervisors	K.M. Dolman M.D. van de Wetering
Award date	26-06-2008
ISBN	9789090232294
Number of pages	217
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	The definitive versions of chapters 2 and 3 are available at www.blackwell-synergy.com. Research conducted at: Universiteit van Amsterdam
Language	English
Downloads	Thesis Cover Titlepage Contents Abbreviations Outline of this thesis Chapter 1: introduction: The effect of mannose-binding lectin (MBL) on the risk of infection in children and adolescents, a systematic review. Chapter 2: High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates Chapter 3: Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis Chapter 4: The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia Chapter 5: Mannose-binding lectin (MBL) as prognostic factor in pediatric oncology patients Chapter 6: MBL2 genotype is associated with Stenotrophomans maltophilia colonization in cystic fibrosis Chapter 7: Mannose-binding lectin (MBL) deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis (JRA): a cohort study Chapter 8: Safety and pharmacokinetics of plasma-derived MBL substitution in children with chemotherapy-induced neutropenia Chapter 9: Mannose-binding lectin (MBL) substitution trial: recovery of opsonic function lags behind MBL serum levels Chapter 10: General discussion Chapter 11: Summary Chapter 12: Dutch summary Acknowledgements Curriculum Vitae
Permalink to this page

Back

UvA-DARE

Digital Academic Repository

The clinical significance of mannose-binding lectin (MBL) deficiency